Sponsor Pipeline

Beijing Immunochina Medical Science & Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
2
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
3
Early Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT04440436 Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's… NHL Recruiting
Phase 1
NCT06718738 Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer Colorectal Cancer (CRC) Recruiting
NCT06852573 Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus… Systemic Lupus Erythematosus Not Yet Recruiting
NCT07406984 Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of… Adenocarcinoma of Gastric Not Yet Recruiting
Early Phase 1
NCT06691308 WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients Recurrent or Progressive Glioblastoma Not Yet Recruiting
NCT06690359 IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients IgA Nephropathy Not Yet Recruiting
NCT06886919 Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for… Difficult to Treat Systemic Lupus Erythematosus Not Yet Recruiting
Disease Areas
Get alerts when Beijing Immunochina Medical Science & Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free